OnKure Therapeutics, Inc.
Ownership
Ownership Structure
Who owns OnKure Therapeutics, Inc. (OKUR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 46.2% of the shares are freely tradable; institutional investors hold 76.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 9.87 | 3,998,333 | +0.0 | 06/30/2026 |
| Bvf Inc | 7.99 | 3,235,778 | +63.5 | 06/30/2026 |
| StepStone Group LLC | 6.57 | 2,660,612 | +0.0 | 06/30/2026 |
| ADAR1 Capital Management LLC | 5.53 | 2,238,684 | -8.1 | 06/30/2026 |
| Vivo Capital, LLC | 4.76 | 1,927,710 | +0.0 | 06/30/2026 |
| Vestal Point Capital LP | 4.51 | 1,825,699 | -0.8 | 06/30/2026 |
| BlackRock Inc | 3.70 | 1,499,845 | +2,924.7 | 06/30/2026 |
| Trails Edge Capital Partners, LP | 3.55 | 1,438,456 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.55 | 1,437,039 | +146.7 | 06/30/2026 |
| Adage Capital Partners Gp LLC | 2.98 | 1,204,819 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Leverone Jason A. | Chief Financial Officer | 18,500 | 53,650 $ | Sep 21, 2026 | direct |
| Saccomano Nicholas A | President and CEO | 11,160 | 32,364 $ | Sep 21, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Leverone Jason A. | Chief Financial Officer | Sell | 302 | 2.97 | 898 |
| Sep 21, 2026 | Saccomano Nicholas A | President and CEO | Sell | 87 | 2.97 | 259 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.